Top Markets
Coin of the day
Regenerative Medical Technology Group Inc. Regenerative Medical Technology Group Inc.

Regenerative Medical Technology Group Inc.

RMTG
Classement en actions #38989
Regenerative Medical Technology Group Inc. operates in the regenerative... Regenerative Medical Technology Group Inc. operates in the regenerative medicine industry in the United States and internationally. It provides products, solutions, equipment, services, and training to doctors and their staff in the application of stem cell therapies. The company is also involved in the treatment of patients; provision of training and seminars; and resale of kits, products, equipment, and services. In addition, it offers reoccurring application of its process using its kits and solutions. The company was formerly known as Meso Numismatics, Inc. and changed its name to Regenerative Medical Technology Group Inc. in May 2024. Regenerative Medical Technology Group Inc. was incorporated in 1999 and is based in Boca Raton, Florida.
Prix de l'action
$0.05315
Dernière synchronisation: 2026-08-14
Capitalisation boursière
$698.34K
Changement (1 jour)
-5.93%
Changement (1 an)
6.30%
Pays
US
Échange Regenerative Medical Technology Group Inc. (RMTG)

Catégorie

Revenus pour Regenerative Medical Technology Group Inc. (RMTG)
Revenus en Aug 2026 TTM : 0
Selon les derniers rapports financiers de Regenerative Medical Technology Group Inc., le chiffre d'affaires actuel de l'entreprise (TTM) est de 0. En 2026, l'entreprise a réalisé un chiffre d'affaires de 0 égal à le chiffre d'affaires de l'année 2026, qui était de 0. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Regenerative Medical Technology Group Inc. de 2026 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
Pas assez de données pour les dates fournies.
Revenus d’entreprises similaires ou concurrentes
Entreprise Revenus Différence de revenus Pays
$12.62B -
US
$6.02B -
NL
- -
CH
- -
KR
$10.11B -
BE